Falma Laboratories

Bengaluru, India Founded: 1989 • Age: 37 yrs
Manufactures and exports high-quality pharmaceutical formulations for global markets.

About Falma Laboratories

Falma Laboratories is a Healthcare company based in Bengaluru (India) founded in 1989. It manufactures and exports high-quality pharmaceutical formulations for global markets. It operates on a B2B model. The company has 1 employees. Its focus areas include Pharmaceuticals, Manufacturing and Formulation Production. Its legal entity in India is Falma Laboratories Private Limited (U24230KA1985PTC007328). Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

Falma Laboratories manufactures and exports high-quality pharmaceutical formulations for global markets through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and formulation production. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Annual Revenue
    ₹21,651

    FY 2022 · -17% YoY

  • Net Loss
    -₹23,245

    FY 2022 · -107% margin

  • EBITDA
    -₹42,300

    FY 2022 · -195% margin

  • Employee Count
    1

Board of directors of Falma Laboratories Private Limited (Falma Laboratories)

Falma Laboratories Private Limited is the primary company behind Falma Laboratories. The board of Falma Laboratories Private Limited currently have 4 directors; the longest-serving is Kollenmareth Oomman Isaac, appointed in 2012. 7 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Kollenmareth Oomman Isaac
DIN 01421392
Director21 Jun 201214 yrs 4 moFalma Laboratories Private Limited
Prabir Kumar Sarkar
DIN 01855794
Additional Director05 Aug 201313 yrs 2 moFalma Laboratories Private Limited
Subhas Banerjee
DIN 05163789
Additional Director01 Jul 201511 yrs 3 moFalma Laboratories Private Limited
Subrata Dasgupta
DIN 03119917
Additional Director15 May 20197 yrs 5 moFalma Laboratories Private Limited

Financials of Falma Laboratories

Figures of Falma Laboratories Private Limited, the primary company behind Falma Laboratories, for FY 2022. Revenue was ₹21,651 (-17% year on year). Net loss was -₹23,245 (-107% margin). EBITDA was -₹42,300 (-195% margin). Revenue has grown at a compounded annual rate of +12% over three years and -3% over five years.

  • ₹21,651Revenue · FY 2022 · -17% YoY
  • -₹23,245Net loss · -107% margin
  • -₹42,300EBITDA · -195% margin
  • ₹30 LakhPaid-up capital
  • +12%Revenue CAGR, 3 years
  • -3%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Falma Laboratories Private Limited are on its company page.

Premium access

Detailed financial statements for Falma Laboratories

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Falma Laboratories

Falma Laboratories has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of Falma Laboratories

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Falma Laboratories

Falma Laboratories was founded in 1989.

Falma Laboratories is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Falma Laboratories has 1 employees.

The primary company behind Falma Laboratories, Falma Laboratories Private Limited, reported revenue of β‚Ή21,651 for FY 2022, down 17% year on year.

Falma Laboratories manufactures and exports high-quality pharmaceutical formulations for global markets through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and formulation production. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Falma Laboratories's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Falma Laboratories operates through Falma Laboratories Private Limited.

The legal entities of Falma Laboratories currently have 4 directors, including Kollenmareth Oomman Isaac, Prabir Kumar Sarkar, Subhas Banerjee and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available